Rutgers Pediatricians Co-Author First Nationwide Study of COVID-19 Related Multiple Inflammatory Syndrome in Children

Researchers describe the diagnosis, treatments and outcomes of MIS-C in NJEM Study
30-Jun-2020 7:55 AM EDT, by Rutgers University-New Brunswick

Newswise — Parents and clinicians need to be aware in looking for symptoms of multiple inflammatory syndrome (MIS-C) in children who have been diagnosed or exposed to COVID-19, according to two Rutgers researchers who were among the leaders of the first nationwide study of the disease, published in the New England Journal of Medicine. MIS-C is defined as an inflammation impacting two or more organ systems within the body, and appears to be a late complication following an infection or exposure to COVID-19. 

Funded by the U.S. Centers for Disease Control and Prevention, the study presents 186 cases of pediatric MIS-C from around the country and another 27 from New York State, from March 16 to May 20.  The article describes clinical characteristics, treatments and outcomes of MIS-C.

“The study highlights our ever-changing understanding of COVID-19 in children,” said Professor Lawrence C. Kleinman, chair for academic development and chief of the Division of Population Health, Quality, and Implementation Sciences in the Department of Pediatrics at the Rutgers Robert Wood Johnson Medical School and Bristol-Myers-Squibb Children’s Hospital. “We have moved from thinking that COVID-19 spares children to understanding that children can get very sick. Children play an important role in the pandemic.”

“This article describes how even in the absence of strong prior evidence, doctors mindfully identified and repurposed potential therapies to positive effect,” added Steven Horwitz, assistant professor of pediatric critical care at the Rutgers Robert Wood Johnson Medical School.  “Individuals with MIS-C can get very sick and many need therapies to support their breathing and their heart function.  Still, with proper identification and treatment, thankfully the majority of these children and adolescents get better and many do so very quickly.” 

Researchers found symptoms of the disease typically appear two to four weeks after the onset of COVID-19 or after exposure to the SARS-CoV2 virus that causes COVID-19.  Among the children confirmed to have had COVID-19, the median time in which inflammatory symptoms appeared was 25 days. More than two-thirds of the children and adolescents were healthy before their experience with SARS-CoV2, and nearly four in five hospitalized with MIS-C required ICU care.  More than two-thirds of the children in the study were over the age of five. As of May 20, 70 percent had been discharged, 28 percent were still hospitalized and 2 percent had died.

With its frequent involvement of the heart and heart vessels, MIS-C initially came to attention as an illness similar to Kawasaki disease.  The NEJM study illustrates that these are distinct syndromes with MIS-C having more frequent and severe involvement of the heart and more typically occurring in an older population.  MIS-C most frequently involves the digestive system.

The study was based out of a collaborative network based in Boston Children’s Hospital. The Rutgers team helped to lead expansion to include many more cases from the original hotspots in the New York and New Jersey region. While the disease is defined as involvement of at least two organ systems, more than two-thirds of cases involved four or more organ systems.

Due to the wide range of symptoms with the disease, including fever, fatigue, rash, shortness of breath, and abdominal pain, parents should seek medical care for children and adolescents who were exposed to COVID-19 and develop these symptoms. 

Researchers stress that the long-term effects of the syndrome are still unknown, as is the possibility that MIS-C exists in a milder form impacting a single organ system, or that does not require hospitalization. They also emphasized the need for clinicians to work together both clinically and in research to expand available evidence to inform better diagnosis and treatment for children. They also encouraged other physicians who may see patients for the first time with symptoms related to MIS-C, to reach out to experienced clinicians for assistance with diagnosis and treatment protocols. 

Hospitals and doctors nationwide are collaborating to continue developing broad protocols for treatment to improve recovery outcomes for our patients and create effective assessments to save lives. 

Simon Li, who will be joining Robert Wood Johnson Medical School as a Chief of Pediatric Critical Care, was a senior co-author of this funded CDC project under a contract to Boston Children’s Hospital.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 2448
Released: 2-Jul-2020 11:25 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.

Released: 2-Jul-2020 8:50 AM EDT
Learn from the pandemic to prevent environmental catastrophe, scientists argue
University of Cambridge

• COVID-19 is comparable to climate and extinction emergencies, say scientists from the UK and US – all share features such as lagged impacts, feedback loops, and complex dynamics. • Delayed action in the pandemic cost lives and economic growth, just as it will with environmental crises – but on a scale “too grave to contemplate”.

Released: 1-Jul-2020 5:30 PM EDT
COVID-19 seed grants awarded to 7 ISU research projects
Iowa State University

Iowa State's COVID-19 Research Seed Grant program will support the initial stages of high-risk/high-reward projects that address the COVID-19 crisis.

Released: 1-Jul-2020 4:30 PM EDT
National Survey on COVID-19 Pandemic Shows Significant Mental Health Impact
Beth Israel Deaconess Medical Center

The findings of a nationwide survey assessing the effects of the COVID-19 pandemic on the emotional wellbeing of U.S. adults show 90 percent of survey respondents reported experiencing emotional distress related to the pandemic.

Released: 1-Jul-2020 2:40 PM EDT
Surveys Reveal Significant Shifts in Consumer Behavior During Pandemic
Rensselaer Polytechnic Institute (RPI)

The COVID-19 pandemic has significantly altered how people shop, how much they buy, the trips they take outside their homes, and the number of tele-activities — like work, medicine, and education — that have become commonplace. These changes were rapid and have tremendously impacted the economy, supply chains, and the environment. Two sets of surveys were conducted by researchers at Rensselaer Polytechnic Institute in an effort to quantify and understand these unprecedented shifts — and evaluate the likelihood they may last after the pandemic has ended.

Released: 1-Jul-2020 2:20 PM EDT
COVID-19 Fatality Risk Is Double Earlier Estimates: Study
Columbia University, Mailman School of Public Health

In one of the most robust studies of COVID-19 mortality risk in the United States, researchers estimate an infection fatality rate more than double estimates from other countries, with the greatest risk to older adults. Columbia University Mailman School of Public Health scientists and New York City Department of Health and Mental Hygiene colleagues published the findings on the pre-print server medRxiv ahead of peer review.

Released: 1-Jul-2020 2:15 PM EDT
Study Examines Limiting School Capacity for New York City Reopening
Columbia University, Mailman School of Public Health

Data modeling projections by Columbia University Mailman School of Public Health scientists evaluate potential policies to reduce new infections, hospitalizations, and deaths in coming months, including by limiting school capacity by 50 percent or capping capacity of certain industries to 25 percent during Phase Four, as well as by implementing an “adaptive PAUSE” system to re-implement social distancing rules during a rebound. The researchers have been working with the New York City Department of Health and Mental Hygiene on COVID-19 planning. Their new report is posted on Github.


Showing results

110 of 2448

close
1.05061